USCCB: PRO LIFE SPOKESWOMAN OBJECTS TO FDA APPROVAL OF “MORNING-AFTER PILL” FOR MINORS WITHOUT PRESCRIPTION

The Food and Drug Administration (FDA) announced late on April 22 that it has expanded over-the-counter access to the morning-after pill, Levonorgestrel or “Plan B,” for 17-year-old minors as well as to adults. Deirdre McQuade, Assistant Director for Policy and Communications at the U.S. Conference of Catholic Bishops’ Secretariat of Pro-Life Activities, objected to the move in the following statement: “The FDA’s court-driven decision to make Plan B available without a prescription to 17-year-old minors – as well as to adults – flies in the face of common sense. Levonorgestrel is a powerful drug, taken in two doses over a 12-hour period. It is 40 times more potent than comparable progestin-only birth control pills (Ovrette) for which a prescription is required. Wider access to Plan B could endanger the lives of newly-conceived children, and will put minors at risk for unnecessary side effects, undermine parental rights, and contribute to higher STD rates.”